59922-631 : Auryxia 210 mg Oral Tablet, Coated
NDC: | 59922-631 |
Labeler: | Keryx Biopharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Auryxia |
Dosage Form: | Oral Tablet, Coated |
Application #: | NDA205874 |
Rev. Date: |
Appearance:
Markings: | KX52 |
Shapes: |
Oval |
Colors: |
Pink |
Size (mm): | 19 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 59922-631-01: 200 TABLET, COATED IN 1 BOTTLE (59922‑631‑01)
- 59922-631-91: 200 TABLET, COATED IN 1 BOTTLE (59922‑631‑91)
- 59922-631-92: 50 TABLET, COATED IN 1 BOTTLE (59922‑631‑92)
Active Ingredients:
- Tetraferric Tricitrate Decahydrate
Dosage Strength:
- 210 mg
Pharmaceutical Classes:
- Iron [CS]
- Parenteral Iron Replacement [EPC]
- Phosphate Binder [EPC]
- Phosphate Chelating Activity [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 59917-113Next: 59922-641 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.